MUKKA · Mukka Proteins Limited · Financials
Volume · Nov 13
23.62K
Avg daily vol (3M)
71.6K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
14.49B
+44%
FY2026
Net Income
520.58M
+12.1%
FY2026
Operating Cash Flow
-1.11B
+0.6%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 |
|---|---|---|---|---|
| INR | 20.33B | 14.49B | 10.06B | 13.8B |
| INR | 195.51M | 165.92M | 135.51M | 123.38M |
| INR | 633.27M | 535.96M | 372.5M | 250.96M |
| INR | — | — | — | 874.56M |
| INR | 332.81M | 180.57M | 121.69M | 131.5M |
| INR | 792.36M | 520.58M | 464.59M | 700.52M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2024–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.